Manufacturing is a critical factor in ADC success. Discover how to align CDMO capabilities with molecule complexity, mitigate risks, and navigate capacity limits.
- Clinical Supply When There's No Drug To Ship
- Why Clinical Supply Problems Rarely Start In Clinical Supply
- The Last Mile Nobody Talks About: What Really Happens To Unused Clinical Trial Supplies
- AI In Clinical Supply: From Forecasting To Execution Decisions
- Accountability Gaps Can Break Clinical Supply Contracts
- When Clinical Supply Becomes A Clinical Decision
- How To Build Clinical Supply Into Drug Development From The Start
- When Communication Fails, Clinical Supply Risk Grows
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Developing Injectable Drug Placebo Formulations For Clinical Trials
Developing a placebo for an injectable drug requires consideration of the formulation’s impact in trials, chemistry and physical details, ethical concerns, and regulatory compliance.
-
RTSM And Clinical Drug Dispensation
A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.
-
How Modern RTSM Platforms Are Eliminating Delays
Stop letting rigid legacy RTSM systems stall your clinical trials. Learn why manual change requests cause months of delays and how a modern, platform-based approach restores your study’s agility.
-
5 Common Clinical Supply Chain Speedbumps
Clinical trials can be very complex. Discover the need to connect planning and oversight from sourcing to shipping, along with mastering requirements such as cold chain, border slowdowns, and data privacy.
-
Inside A Gene Therapy Facility, Commercialization & Industrialization Project
An inside look at a clinical-stage company focused on bringing its gene therapy from the lab into a clinical setting for patients and families devastated by rare neurological genetic diseases.
-
Optimizing Clinical Supply Management With A One-Team Approach
See how NewAmsterdam Pharma managed 11 global studies across 51 countries and 835 sites for 12,000+ patients without overwhelming their internal team.
-
Industry Trends: Clinical Logistics Outsourcing
Understanding industry trends, market dynamics, and the selection criteria decision-makers apply when choosing a clinical logistics service provider informs and contextualizes outsourcing decisions.
-
Logistics In Cell Therapy: Reducing Workflow Risk
Explore key steps that should be taken when executing a cell therapy clinical trial, from selecting the right sites to optimizing study retention.
-
The Tale Of Two Clinical Supply Chains: The Risks Of Fragmented Systems
Here we examine two contrasting approaches to showcase how a centralized inventory management system is an effective tool for supporting a robust supply chain.
-
Key Considerations For Labeling Your Cell Or Gene Therapy
As sponsors focus on maintaining the temperature range required for cell and gene therapies, they must also keep in mind the challenges this task presents when properly labeling them for clinical trial distribution.
- Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next
- The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon.
- How Clinical Supply Is Shaping The Next Generation Of Cell And Gene Therapies
- First Advisors In: Meet Clinical Supply Leader's Inaugural Board Members
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.